Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹69.2 Cr -4.6% -4.6% -61.7% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,049.9 Cr 1.3% -8.9% -20% Stock Analytics
KIRI INDUSTRIES ₹2,897.9 Cr -10.3% -16.3% -17.9% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,565.3 Cr -6.4% -7.2% -35.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,137.2 Cr 5.6% -9.2% 4.4% Stock Analytics
BODAL CHEMICALS ₹597.2 Cr -4.9% -10.9% -28.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-4.6%

-4.6%

-61.7%

SENSEX

-1.3%

-3.1%

6.8%


You may also like the below Video Courses